Background Male breast cancer (MBC) is a rare malignancy. We aimed to analyze the
incidence trends, clinicopathological characteristics, and survival outcomes in early MBC …

Purpose Male breast cancer (MBC) is a rare, but increasingly common disease, and lacks
prospective studies. Collaborative efforts are needed to understand and address MBC …

Objective Male breast cancer (MBC) is a rare disease, and studies to compare the prognosis
between the MBC and female breast cancer (FBC) available now were case-control studies …

Purpose Male breast cancer (MBC) represents< 1% of breast cancer patients, and limited
data exists regarding metastatic MBC. To better characterize this patient subset, we …

Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …

Male breast cancer (MBC) is rare. Due to limited information, MBC has always been
understudied. We conducted a retrospective population-based cohort study using data from …

Background Male breast cancer (MBC) is rare. Given the paucity of randomized trials,
treatment is generally extrapolated from female breast cancer guidelines. Methods This is a …

Purpose To evaluate the clinicopathological features, patterns of distant metastases, and
survival outcome between stage IV male breast cancer (MBC) and female breast cancer …

Aims Male breast cancer is a rare disease with limited evidence-based guidelines for
treatment. This study aimed to identify demographic, pathological and clinical factors …

Introduction Male breast cancer (MBC) accounts for 0.5% to 1% of all breast cancers
diagnosed annually. The purpose of this study is to evaluate prognostic factors in MBC …